| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91c339a23bfbcd734c052ab72540316f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7317808024e524eea40a6c5a5ad6a22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4a1a1d57ba36af661889a871b6ea868
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_de9b0746a5cd99ca2fd18264023ed4c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12aa523172b20cad708e8008b1ee1950 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-14542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-14503
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-0002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-1052 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-14546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12109 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-958 |
| filingDate |
2010-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c3747f2c3acde4056cca2d4a6a22b89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61d85dc4cca1730248b424bb509968cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_691e84ba52eff6af9c67953664205ccb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_554b2709dbc38a674151f98a4a1f93f4 |
| publicationDate |
2012-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012165853-A1 |
| titleOfInvention |
Femoral Vein Catheter for Improving Cardiac Output, Drug Delivery and Automated CPR Optimization |
| abstract |
A blood flow control device, comprising a flow influencing element arranged to be placed in the vena cava of a human during cardiopulmonary resuscitation and controllable between a non-to-low-flow state in which the flow influencing element substantially reduces a blood flow within the vena cava, and a flow state, in which the flow influencing element allows substantially unreduced blood flow, responsive to an existing or a predicted pressure difference between an upstream area and a downstream area of the flow influencing element. The blood flow control device is capable of reducing retrograde blood flow during the compression phase of CPR and thus improves the efficiency of CPR and blood perfusion. The blood flow control device can also be used for the administration of drugs almost directly to the heart, as well as for measuring physiological and chemical properties, such as blood gases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11234896-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10143789-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11058864-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108778358-A |
| priorityDate |
2009-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |